生物制药巨头安进（AMGN）周三盘中股价大涨5.16%，创下7个多月以来的新高。此轮涨势主要受到公司第三季度财报超预期以及上调全年业绩指引的推动。
根据安进公布的财报，公司第三季度销售额达95.6亿美元，同比增长12%，远超分析师预期的89.7亿美元。调整后每股收益为5.64美元，同样高于市场预期的5.01美元。值得注意的是，安进的产品组合展现出强劲增长势头，其中16种产品的销售额实现了两位数的增长。
在亮眼业绩的支撑下，安进上调了全年业绩指引。公司预计全年销售额将达到358亿至366亿美元，较此前350亿至360亿美元的预期有所提高。每股收益预期也从20.2至21.3美元上调至20.6至21.4美元。这一指引优于分析师平均预期的21.04美元。强劲的财务表现和乐观的未来展望无疑增强了投资者对安进的信心，推动其股价大幅上涨。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.